Haonan Li

State Key Laboratory Of Anti Infective Drug Discovery And Development
Guangzhou, 510006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Structure-Based Development of a Novel Macrocyclic Peptide to Disrupt the Lumican-Collagen I Interaction in Liver Fibrosis.

Structure-Based Development of a Novel Macrocyclic Peptide to Disrupt the Lumican-Collagen I Interaction in Liver Fibrosis.

Journal: Journal of medicinal chemistry

Published: November 28, 2025

Fast capillary flow on μPADs with hollow channels packaged by a thermal contraction tube.

Fast capillary flow on μPADs with hollow channels packaged by a thermal contraction tube.

Journal: Lab on a chip

Published: June 25, 2025

Discovery of Novel Peptide Antagonists Targeting GPR55 for Liver Inflammation and Fibrosis.

Discovery of Novel Peptide Antagonists Targeting GPR55 for Liver Inflammation and Fibrosis.

Journal: Journal of medicinal chemistry

Published: July 11, 2024

Design and Discovery of Novel Cyclic Peptides as EDPs-EBP Interaction Inhibitors for the Treatment of Liver Fibrosis.

Design and Discovery of Novel Cyclic Peptides as EDPs-EBP Interaction Inhibitors for the Treatment of Liver Fibrosis.

Journal: Journal of medicinal chemistry

Published: March 20, 2023

Cost-effectiveness analysis of COVID-19 screening strategy under China's dynamic zero-case policy.

Cost-effectiveness analysis of COVID-19 screening strategy under China's dynamic zero-case policy.

Journal: Frontiers in public health

Published: November 15, 2022

Correction to: CCR9 initiates epithelial-mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis.

Correction to: CCR9 initiates epithelial-mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis.

Journal: Cancer cell international

Published: April 06, 2022

CCR9 initiates epithelial-mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis.

CCR9 initiates epithelial-mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis.

Journal: Cancer cell international

Published: August 03, 2021

Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.

Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.

Journal: Hepatology (Baltimore, Md.)

Published: June 14, 2021

Identification of MAP3K15 as a potential prognostic biomarker and correlation with immune infiltrates in osteosarcoma.

Identification of MAP3K15 as a potential prognostic biomarker and correlation with immune infiltrates in osteosarcoma.

Journal: Annals of translational medicine

Published: May 28, 2021

Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.

Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.

Journal: Hepatology (Baltimore, Md.)

Published: October 07, 2020

Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.

Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.

Journal: Journal of hepatology

Published: September 09, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026